Clinical observation of methimazole combined with Selenious in the treatment of hyperthyroidism
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.1008-6706.2018.06.004
   		
        
        	
        		- VernacularTitle:甲巯咪唑联合硒酵母片治疗甲状腺功能亢进症的临床观察
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Shuoliang LI
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Xiujuan FENG
			        		
			        		;
		        		
		        		
		        		
			        		Qihe WU
			        		
			        		;
		        		
		        		
		        		
			        		Huaping HE
			        		
			        		;
		        		
		        		
		        		
			        		Meiyan HE
			        		
			        		;
		        		
		        		
		        		
			        		Ruizhu TAN
			        		
			        		;
		        		
		        		
		        		
			        		Hongju LEI
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 台山市人民医院内分泌科
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Thiamazole;
			        		
			        		
			        		
				        		Selenious;
			        		
			        		
			        		
				        		Hyperthyroidism
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Primary Medicine and Pharmacy
	            		
	            		 2018;25(6):692-695
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To assess the efficacy and safety of methimazole combined with selenium therapy in the treatment of hyperthyroidism .Methods 130 cases with hyperthyroidism were selected , and according to the digital table they were randomly divided into methimazole plus selenium treatment group ( ATD +Se group ) and methimazole treatment group(ATD group),65 cases in each group.The patients were followed up for 3 months.The thyroid function index and thyroid antibody index were observed before and after treatment .The adverse reactions were observed,too.Results After treatment,the serum levels of FT3,FT4,TSH in the ATD +Se group were (3.32 ± 0.53)pg/mL,(1.02 ±0.17)ng/dL,(2.72 ±0.32)mIU/L,respectively,which in the ATD group were (4.82 ± 0.75)pg/mL,(2.41 ±0.32)ng/dL,(2.72 ±0.32)mIU/L,respectively.The change ranges of the ATD +Se group were better than those of the ATD group ,the differences were statistically significant (t=4.591,3.814,3.567,all P<0.05).The TPOAb,TGAb,TRAb in the ATD+Se group were (120.3 ±23.1) IU/mL,(123.3 ±26.5) IU/mL, (1.72 ±0.89)IU/mL,respectively,which in the ATD group were (132.8 ±21.1)IU/mL,(134.8 ±21.3)IU/mL, (3.68 ±1.06)IU/mL,respectively.The changes of the ATD+Se group were more significant than those of the ATD group,the differences were statistically significant (t=4.291,3.514,3.767,all P<0.05 ).The total effective rate of the ATD+Se group was higher than that of the ATD group (90.77%vs.76.92%χ2 =13.147,P<0.05 ).The incidence rate of adverse reactions in the ATD +Se group was lower than that in the ATD group (12.31%vs.27.69%χ2 =18.685,P<0.05 ).Conclusion The results suggest that methimazole combined with selenium treatment is effective and safe for hyperthyroidism .